Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...

The revenue increase leaders of the fourth quarter were familiar—Eli Lilly (45%) and Novo Nordisk ... drug conjugate drugs brought by the Seattle biotech—played a significant role in boosting ...

The bonus is part of a bid to induce CFO Cathy Smith to join the coffee retailer as well as to help her recoup some of the ...

Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022 The following represents disclosure information provided by ...

Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022 Fig 1. Challenges in the management of advanced prostate cancer.

Loi reported relationships with Bristol Myers Squibb, Puma Biotechnology, AstraZeneca-Daiichi Sankyo, Novartis, Roche-Genentech, Seattle Genetics, MSD, Gilead Sciences, Eli Lilly, Amaroq ...

Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity treatments because a wide swath of the population could be eligible to take them ...

Many celebrities are investing in NWSL franchises, including Kevin Durant, Serena Williams, Patrick Mahomes and more.